Catalyst Wire Dossier Catalyst Wire Dossier

1PC111

· Orient Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 1PC111, covering 2022-05-18 to 2022-05-18. Get the full timeline:

Most recent: Clinical Trial Update: Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia [Phase 3]

See pricing